These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 21507586)
61. The DSM-IV criteria for adolescent alcohol and cannabis use disorders. Winters KC; Latimer W; Stinchfield RD J Stud Alcohol; 1999 May; 60(3):337-44. PubMed ID: 10371261 [TBL] [Abstract][Full Text] [Related]
62. Greater Prevalence of Proposed ICD-11 Alcohol and Cannabis Dependence Compared to ICD-10, DSM-IV, and DSM-5 in Treated Adolescents. Chung T; Cornelius J; Clark D; Martin C Alcohol Clin Exp Res; 2017 Sep; 41(9):1584-1592. PubMed ID: 28667763 [TBL] [Abstract][Full Text] [Related]
63. Characteristics of DSM-IV and ICD-10 cannabis dependence among Australian adults: results from the National Survey of Mental Health and Wellbeing. Swift W; Hall W; Teesson M Drug Alcohol Depend; 2001 Jul; 63(2):147-53. PubMed ID: 11376919 [TBL] [Abstract][Full Text] [Related]
64. The association between cannabis abuse and dependence and childhood physical and sexual abuse: evidence from an offspring of twins design. Duncan AE; Sartor CE; Scherrer JF; Grant JD; Heath AC; Nelson EC; Jacob T; Bucholz KK Addiction; 2008 Jun; 103(6):990-7. PubMed ID: 18482422 [TBL] [Abstract][Full Text] [Related]
65. Cannabis dependence in the San Francisco Family Study: age of onset of use, DSM-IV symptoms, withdrawal, and heritability. Ehlers CL; Gizer IR; Vieten C; Gilder DA; Stouffer GM; Lau P; Wilhelmsen KC Addict Behav; 2010 Feb; 35(2):102-10. PubMed ID: 19818563 [TBL] [Abstract][Full Text] [Related]
66. Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10). Hasin D; Hatzenbuehler ML; Keyes K; Ogburn E Addiction; 2006 Sep; 101 Suppl 1():59-75. PubMed ID: 16930162 [TBL] [Abstract][Full Text] [Related]
67. A validation of the Cannabis Abuse Screening Test (CAST) using a latent class analysis of the DSM-IV among adolescents. Legleye S; Piontek D; Kraus L; Morand E; Falissard B Int J Methods Psychiatr Res; 2013 Mar; 22(1):16-26. PubMed ID: 23519957 [TBL] [Abstract][Full Text] [Related]
68. Withdrawal symptoms do not predict relapse among subjects treated for cannabis dependence. Arendt M; Rosenberg R; Foldager L; Sher L; Munk-Jørgensen P Am J Addict; 2007; 16(6):461-7. PubMed ID: 18058411 [TBL] [Abstract][Full Text] [Related]
69. The relationship between cannabis use and DSM-IV cannabis abuse and dependence: results from the National Longitudinal Alcohol Epidemiologic Survey. Grant BF; Pickering R J Subst Abuse; 1998; 10(3):255-64. PubMed ID: 10689658 [TBL] [Abstract][Full Text] [Related]
70. [Cannabis withdrawal syndrome in patients with cannabis dependence only, and in patients with cannabis and opioid dependence]. Vorspan F; Guillem E; Bloch V; Bellais L; Sicot R; Noble F; Lepine JP; Gorelick DA Encephale; 2011 Sep; 37(4):266-72. PubMed ID: 21981886 [TBL] [Abstract][Full Text] [Related]
71. DSM-IV criteria endorsement patterns in alcohol dependence: relationship to severity. Moss HB; Chen CM; Yi HY Alcohol Clin Exp Res; 2008 Feb; 32(2):306-13. PubMed ID: 18162067 [TBL] [Abstract][Full Text] [Related]
72. Cannabis Withdrawal in Adults With Attention-Deficit/Hyperactivity Disorder. Chauchard E; Hartwell KJ; McRae-Clark AL; Sherman BJ; Gorelick DA Prim Care Companion CNS Disord; 2018 Feb; 20(1):. PubMed ID: 29489073 [TBL] [Abstract][Full Text] [Related]
73. The craving withdrawal model for alcoholism: towards the DSM-V. Improving the discriminant validity of alcohol use disorder diagnosis. de Bruijn C; van den Brink W; de Graaf R; Vollebergh WA Alcohol Alcohol; 2005; 40(4):314-22. PubMed ID: 15883129 [TBL] [Abstract][Full Text] [Related]
74. Psychometric properties of the CAST and SDS scales in young adult cannabis users. Cuenca-Royo AM; Sánchez-Niubó A; Forero CG; Torrens M; Suelves JM; Domingo-Salvany A Addict Behav; 2012 Jun; 37(6):709-15. PubMed ID: 22386300 [TBL] [Abstract][Full Text] [Related]
75. The DSM Guided Cannabis Screen (DSM-G-CS): description, reliability, factor structure and empirical scoring with a clinical sample. Alexander D; Leung P Addict Behav; 2011 Nov; 36(11):1095-100. PubMed ID: 21741769 [TBL] [Abstract][Full Text] [Related]
76. Gender differences in cannabis use disorder symptoms: A network analysis. Kroon E; Mansueto A; Kuhns L; Filbey F; Wiers R; Cousijn J Drug Alcohol Depend; 2023 Feb; 243():109733. PubMed ID: 36565568 [TBL] [Abstract][Full Text] [Related]
77. A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults. Mason BJ; Crean R; Goodell V; Light JM; Quello S; Shadan F; Buffkins K; Kyle M; Adusumalli M; Begovic A; Rao S Neuropsychopharmacology; 2012 Jun; 37(7):1689-98. PubMed ID: 22373942 [TBL] [Abstract][Full Text] [Related]
78. Reliability and validity of the Severity of Dependence Scale for detecting cannabis dependence in frequent cannabis users. van der Pol P; Liebregts N; de Graaf R; Korf DJ; van den Brink W; van Laar M Int J Methods Psychiatr Res; 2013 Jun; 22(2):138-43. PubMed ID: 23670783 [TBL] [Abstract][Full Text] [Related]
79. Cannabis expectancies in substance misusers: French validation of the Marijuana Effect Expectancy Questionnaire. Guillem E; Notides C; Vorspan F; Debray M; Nieto I; Leroux M; Lépine JP Am J Addict; 2011; 20(6):543-54. PubMed ID: 21999501 [TBL] [Abstract][Full Text] [Related]
80. Pathways to cannabis abuse: a multi-stage model from cannabis availability, cannabis initiation and progression to abuse. Gillespie NA; Neale MC; Kendler KS Addiction; 2009 Mar; 104(3):430-8. PubMed ID: 19207351 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]